| Stroke. 'Spotting' patients at the highest risk of hematoma growth. | |
| | |
MedLine Citation:
|
PMID: 19794510 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Clinical trials aimed at preventing hematoma expansion in patients with intraparenchymal hemorrhage have failed to show benefit from experimental intervention. novel methods for identifying those patients at the highest risk of hemorrhage growth might enable better patient selection and, hence, increase the chance of demonstrating an improvement in clinical outcome. |
| | |
Authors:
|
Kyra Becker; David Tirschwell |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Nature reviews. Neurology Volume: 5 ISSN: 1759-4766 ISO Abbreviation: Nat Rev Neurol Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-10-01 Completed Date: 2009-12-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101500072 Medline TA: Nat Rev Neurol Country: England |
Other Details:
|
Languages: eng Pagination: 526-8 Citation Subset: IM |
Affiliation:
|
University of Washington School of Medicine, Harborview Medical Center, 325 9th Avenue,Seattle, WA 98104, USA. kjb@u.washington.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cerebral Angiography Clinical Trials as Topic Hematoma / etiology*, radiography* Humans Risk Factors Stroke / complications* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neurodegenerative disease. Genetic discrimination in Huntington disease.
Next Document: Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.